✉news CultureArt first seen 6 h ago, last 49 min ago, peak #6
Long-Acting Cabotegravir/Rilpivirine Injection Found Superior to Daily Oral HIV Treatment
Original: Long-Acting Cabotegravir/Rilpivirine Superior to Daily Oral ART for HIV
A report states that long-acting cabotegravir/rilpivirine, an injectable two-drug regimen given less frequently than daily pills, is superior to daily oral antiretroviral therapy for treating HIV. If confirmed in clinical data, the finding could mark a shift in how HIV maintenance treatment is delivered, offering patients an alternative to strict daily adherence regimens.
Why now: New evidence suggesting an injectable regimen outperforms standard daily HIV therapy has major implications for treatment practice.
Rank over time, top of the chart is #1. 5 snapshots from 6 h ago to 49 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1261236